GRST · As filed with the SEC

Ethema Health cash flow statement, by quarter

The statement as Ethema Health presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.

CONSOLIDATED STATEMENTS OF CASH FLOWS · USD

USD	Q4 2025^† 3 months ended Dec 31, 2025	Q3 2025^† 3 months ended Sep 30, 2025	Q2 2025^† 3 months ended Jun 30, 2025	Q1 2025 3 months ended Mar 31, 2025
Profit or Loss	(1,063,179)^†	66,136^†	—	—
Adjustment to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	206,597^†	206,196^†	203,265^†	196,221
Amortization of debt discount	168,038^†	158,064^†	160,088^†	129,882
Other Operating Expense	357,748^†	0^†	0^†	103,012
Net Cash from Operating Activities	295,725^†	269,940^†	245,707^†	205,790
Deferred taxation movement	(13,434)^†	(13,434)^†	(13,434)^†	(12,342)
Accounts receivable	568,001^†	(907,798)^†	(490,168)^†	(93,139)
Prepaid expenses	7,379^†	(24,409)^†	(14,924)^†	3,547
Other current assets	0^†	28,130^†	731^†	32,229
Accounts payable and accrued liabilities	348,630^†	424,047^†	(14,476)^†	327,134
Related party accruals	(445,463)^†	112,646^†	2,586^†	47,758
Net Cash from Operating Activities	(123,783)^†	(195,894)^†	(173,189)^†	(128,411)
Net cash used in operating activities	306,259^†	123,624^†	(389,343)^†	(73,416)
Investing activities
Acquisition of ARIA Kentucky, net of cash of $299,492	0^†	0^†	0^†	49,492
Purchase of property and equipment	(119,024)^†	(79,896)^†	(66,193)^†	(12,627)
Investment in deposits	0^†	0^†	(718)^†	(24,713)
Net cash used in investing activities	(119,024)^†	(79,896)^†	(66,911)^†	12,152
Financing activities
Repayment of assumed liability	0^†	0^†	(82,913)^†	(76,172)
Proceeds from bank loans	0^†	0^†	—	—
Repayment of bank loans	(78,753)^†	(8,935)^†	(8,688)^†	(25,000)
Proceeds from short term notes	0^†	70,000^†	—	—
Repayment of short-term notes	1^†	(83,500)^†	—	—
Repayment of promissory notes	(30,000)^†	(40,000)^†	(40,000)^†	(30,000)
Proceeds from funding arrangements	736,375^†	346,000^†	888,500^†	667,875
Repayment of funding arrangements	(843,797)^†	(643,328)^†	(590,412)^†	(486,509)
Repayment of finance leases	—	—	(2,232)^†	(2,199)
Proceeds from related parties	—	—	52,429^†	(21,429)
Net cash provided by financing activities	(248,282)^†	(363,232)^†	666,807^†	26,566
Effect of Exchange Rate on Cash	6,526^†	(8,190)^†	20,725^†	373
Net change in cash	(54,521)^†	(327,694)^†	231,278^†	(34,325)
Beginning cash balance	114,030	441,724	210,446	244,771
Ending cash balance	59,509	114,030	441,724	210,446
Supplemental cash flow information
Interest Expense	179,081^†	79,794^†	338,989^†	98,056
Non-cash investing and financing activities
Present value of operating lease liability and operating lease right of use assets recognized in connection with lease commencement	0^†	0^†	0^†	1,149,642
Present value of operating lease liability and operating lease right of use assets recognized in connection with lease commencement – Related parties	0^†	1,243,831^†	0^†	7,622,084
Common shares cancelled	0^†	0^†	0^†	27,700
Bank loan proceeds applied directly to sellers’ debt in connection with acquisition	0^†	4,245,750^†	0^†	4,250
Related party loan proceeds applied directly to sellers’ debt in connection with acquisition	0^†	0^†	0^†	66,741
Net loss	—	—	—	(885,097)

† Derived: worked out from the filings, not stated in them. A fourth quarter is the 10-K year less the nine months in the third-quarter 10-Q; a quarter of cash flows is year to date less the prior year to date.

As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.